Heron Therapeutics (NASDAQ: HRTX) CEO converts 84,810 RSUs to shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Heron Therapeutics Chief Executive Officer Craig A. Collard exercised restricted stock units into common stock in a compensation-related transaction. He acquired 50,021 shares and 34,789 shares of common stock upon conversion of RSUs, reflecting previously granted equity awards that vest over time rather than open-market purchases or sales. Collard’s RSU program includes a grant of 800,337 units that vest in 16 equal quarterly installments beginning after the January 30, 2026 date of grant. Footnotes also note 11,023 shares acquired under the company’s Employee Stock Purchase Plan on April 30, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
84,810 shares exercised/converted
Mixed
4 txns
Insider
Collard Craig A
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 34,789 | $0.00 | -- |
| Exercise | Restricted Stock Units | 50,021 | $0.00 | -- |
| Exercise | Common Stock | 34,789 | $0.00 | -- |
| Exercise | Common Stock | 50,021 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 382,675 shares (Direct, null);
Common Stock — 696,841 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of common stock. Includes 11,023 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2026. The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025). On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant.
Key Figures
RSUs converted to common stock: 50,021 shares
Additional RSUs converted: 34,789 shares
Total RSU exercise shares: 84,810 shares
+4 more
7 metrics
RSUs converted to common stock
50,021 shares
Common stock acquired from RSU exercise on April 30, 2026
Additional RSUs converted
34,789 shares
Common stock acquired from RSU exercise on April 30, 2026
Total RSU exercise shares
84,810 shares
ExerciseShares in transaction summary for derivative exercises
New RSU grant size
800,337 units
RSUs granted on January 30, 2026 (Date of Grant)
RSU vesting schedule
16 installments
Equal quarterly vesting installments after the January 30, 2026 grant
ESPP shares acquired
11,023 shares
Shares acquired under 1997 Employee Stock Purchase Plan on April 30, 2026
RSU conversion price
$0.00 per share
Stated transaction price per share for RSU exercises
Key Terms
Restricted Stock Units, Employee Stock Purchase Plan, Date of Grant, derivative exercise/conversion, +1 more
5 terms
Restricted Stock Units financial
"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Purchase Plan financial
"Includes 11,023 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Date of Grant financial
"On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs"
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
restricted stock unit financial
"Each restricted stock unit represents a contingent right to receive one share of common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
FAQ
What did Heron Therapeutics (HRTX) CEO Craig Collard report in this Form 4?
Craig Collard reported exercising restricted stock units into common stock. He acquired 50,021 and 34,789 shares through RSU conversions, reflecting equity compensation vesting rather than open-market buying or selling activity in Heron Therapeutics shares.
What are restricted stock units (RSUs) in the Heron Therapeutics (HRTX) filing?
In this filing, each RSU represents a contingent right to receive one common share. When vesting conditions are satisfied, the RSUs convert into Heron Therapeutics stock, as shown by the CEO’s April 30, 2026 exercises into common shares at a stated price of $0.00.
How large is Craig Collard’s RSU grant at Heron Therapeutics (HRTX)?
On January 30, 2026, Craig Collard received a grant of 800,337 restricted stock units. According to the footnotes, these RSUs vest in 16 equal quarterly installments, starting one quarter after the grant date, gradually delivering common shares over four years.